INVO Fertility (IVF) Competitors $2.19 -0.41 (-15.77%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock IVF vs. HSAQ, GBS, PETV, RVP, BTCY, NAYA, DYNT, TTOO, IONM, and AFIBShould you be buying INVO Fertility stock or one of its competitors? The main competitors of INVO Fertility include Health Sciences Acquisitions Co. 2 (HSAQ), GBS (GBS), PetVivo (PETV), Retractable Technologies (RVP), Biotricity (BTCY), NAYA Biosciences (NAYA), Dynatronics (DYNT), T2 Biosystems (TTOO), Assure (IONM), and Acutus Medical (AFIB). These companies are all part of the "surgical & medical instruments" industry. INVO Fertility vs. Its Competitors Health Sciences Acquisitions Co. 2 GBS PetVivo Retractable Technologies Biotricity NAYA Biosciences Dynatronics T2 Biosystems Assure Acutus Medical Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) and INVO Fertility (NASDAQ:IVF) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, dividends, institutional ownership, media sentiment, risk, profitability, analyst recommendations and valuation. Which has preferable valuation and earnings, HSAQ or IVF? Health Sciences Acquisitions Co. 2 has higher earnings, but lower revenue than INVO Fertility. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHealth Sciences Acquisitions Co. 2N/AN/A-$380KN/AN/AINVO Fertility$6.53M0.24-$9.10MN/AN/A Does the media refer more to HSAQ or IVF? In the previous week, INVO Fertility had 2 more articles in the media than Health Sciences Acquisitions Co. 2. MarketBeat recorded 2 mentions for INVO Fertility and 0 mentions for Health Sciences Acquisitions Co. 2. Health Sciences Acquisitions Co. 2's average media sentiment score of 0.00 beat INVO Fertility's score of -2.00 indicating that Health Sciences Acquisitions Co. 2 is being referred to more favorably in the media. Company Overall Sentiment Health Sciences Acquisitions Co. 2 Neutral INVO Fertility Very Negative Which has more risk and volatility, HSAQ or IVF? Health Sciences Acquisitions Co. 2 has a beta of 0.09, meaning that its stock price is 91% less volatile than the S&P 500. Comparatively, INVO Fertility has a beta of 2.04, meaning that its stock price is 104% more volatile than the S&P 500. Do insiders & institutionals believe in HSAQ or IVF? 89.7% of Health Sciences Acquisitions Co. 2 shares are held by institutional investors. Comparatively, 12.0% of INVO Fertility shares are held by institutional investors. 21.9% of Health Sciences Acquisitions Co. 2 shares are held by insiders. Comparatively, 0.6% of INVO Fertility shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Is HSAQ or IVF more profitable? Health Sciences Acquisitions Co. 2 has a net margin of 0.00% compared to INVO Fertility's net margin of -377.73%. Company Net Margins Return on Equity Return on Assets Health Sciences Acquisitions Co. 2N/A N/A -2.38% INVO Fertility -377.73%N/A -88.18% SummaryHealth Sciences Acquisitions Co. 2 beats INVO Fertility on 6 of the 9 factors compared between the two stocks. Get INVO Fertility News Delivered to You Automatically Sign up to receive the latest news and ratings for IVF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IVF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IVF vs. The Competition Export to ExcelMetricINVO FertilitySurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.58M$65.65M$5.67B$9.49BDividend YieldN/AN/A4.05%4.00%P/E Ratio-0.026.0527.9419.95Price / Sales0.24142.51396.5882.68Price / CashN/A18.4136.1958.45Price / Book-0.027.348.635.82Net Income-$9.10M-$25.32M$3.24B$258.42M7 Day Performance-10.96%1.79%3.22%1.94%1 Month Performance-31.78%6.08%10.72%12.02%1 Year Performance-91.85%56.17%34.94%20.80% INVO Fertility Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IVFINVO FertilityN/A$2.19-15.8%N/A-90.9%$1.58M$6.53M-0.0225Negative NewsStock SplitHSAQHealth Sciences Acquisitions Co. 2N/A$3.16+2.3%N/A-60.4%$35.43MN/A0.004GBSGBSN/A$2.15+0.5%N/A+63.0%$32.01MN/A-3.847News CoveragePETVPetVivoN/A$0.84+0.6%N/A+33.5%$20.41M$1.05M-1.8620RVPRetractable Technologies2.0575 of 5 stars$0.67+0.8%N/A-37.6%$20.06M$33.75M-1.24240News CoverageBTCYBiotricityN/A$0.51+6.3%N/A-39.4%$12.71M$12.06M-0.4740Analyst RevisionGap DownNAYANAYA BiosciencesN/A$2.55+0.9%$24.00+841.2%N/A$1.70M$6.23M0.0010Gap UpHigh Trading VolumeDYNTDynatronicsN/A$0.08flatN/A-71.0%$1.03M$33.60M-0.10200TTOOT2 BiosystemsN/A$0.02-0.5%$5.00+24,900.0%-99.6%$421K$7.68M0.00180Upcoming EarningsGap UpIONMAssureN/A$0.05+65.5%N/A-98.0%$150K$149K0.00130Gap UpAFIBAcutus MedicalN/A$0.00flatN/A-99.5%$40K$7.16M0.00340 Related Companies and Tools Related Companies Health Sciences Acquisitions Co. 2 Competitors GBS Competitors PetVivo Competitors Retractable Technologies Competitors Biotricity Competitors NAYA Biosciences Competitors Dynatronics Competitors T2 Biosystems Competitors Assure Competitors Acutus Medical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IVF) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersElon Just Fired the IRS Agents Targeting Your SavingsElon Musk just fired 6,700 IRS agents — and exposed a war on your retirement. While D.C. scrambles to regai...Priority Gold | SponsoredFREE GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...GoldCo Precious Metals | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredBREAKING: The House just passed 3 pro-crypto bills!Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the coun...Crypto 101 Media | SponsoredWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredTrump’s $100 Trillion Land Rush Is OnWhat Is "The US: IPO"? You won't hear this on CNBC... but the government may soon open up hundreds of trill...Stansberry Research | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding INVO Fertility, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share INVO Fertility With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
